Acute stress in patients with brain cancer during primary care

Goebel, Simone; Strenge, H; Mehdorn, H. Maximilian

doi:10.1007/s00520-011-1225-6

Cited by 35 publications

(12 citation statements)

References 46 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Being diagnosed with a brain tumor is associated with psychosocial distress [4,17,18]. Irrespective of the prognosis, patients are prone to psychological comorbidities such as adjustment disorder and depression [4,12].…”

Section: Discussionmentioning

confidence: 99%

Suicidal ideation, depression, and health-related quality of life in patients with benign and malignant brain tumors: a prospective observational study in 83 patients

et al. 2016

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Suicidal ideation, depression, and health-related quality of life in patients with benign and malignant brain tumors: a prospective observational study in 83 patients

et al. 2016

View full text Add to dashboard Cite

show abstract

“…This is in agreement with the finding reported in all cancer patients in the original CCOP study. 18 A wide range of the reported prevalence of CAM use can be found in literature 32 : 80% patients with early breast cancer had used CAM during treatment, 33 and about 66% breast cancer survivors used CAM in the previous 12 months; most commonly used CAM treatments were relaxation or meditation, herbs, and “spiritual healing.” 34 This has varied with the heterogeneous samples of populations studied, study designs, types of cancers and CAM modalities, and time of study relative to cancer experience. Another such example is a prospective study of women with early breast cancer in Australia where 16.4% had consulted a CAM practitioner and 11% had used one of the CAM products (hormonal or herbal) commonly used for relief of menopausal symptoms in the previous 12 months in comparison to about 7% at the time of diagnosis.…”

Section: Discussionmentioning

confidence: 99%

Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer

Chandwani

Heckler

Mohile

et al. 2014

EXPLORE

View full text Add to dashboard Cite

Context Hot flashes (HF) are a common distressing symptom in women with breast cancer (BC). Current pharmacologic options are moderately effective and are associated with bothersome side effects. Complementary and alternative medicine is commonly used by cancer patients. However, information on the association of hot flashes severity with such use and self-rated health is lacking. Objective To examine the hot flashes severity in women with breast cancer and its association with complementary and alternative medicine use and self-rated health (SRH). Design Longitudinal multicenter study to assess information needs of cancer outpatients. Participants Patients with a diagnosis of breast cancer who were scheduled to undergo chemotherapy and/or radiotherapy. Outcome Measures Hot flashes severity (0 = not present and 10 = as bad as you can imagine), use of complementary and alternative medicine (yes/no), and self-rating of health (SRH) status post-treatment and six-months thereafter (1–5, higher score = better SRH). Results The majority of women with HF (mean age = 54.4 years) were Caucasian and married, with higher education, and 93% had received surgical treatment for BC. At the end of treatment, 79% women reported experiencing HF [mean severity = 5.87, standard deviation (SD) = 2.9]; significantly more severe HF were reported by younger women with poor SRH, better performance status, and those reporting doing spiritual practices. At follow-up, 73% had HF (mean severity = 4.86, SD = 3.0), and more severe HF were reported by younger women with poor self-rated health who had undergone chemotherapy plus radiotherapy, used vitamins, and did not exercise. Conclusions A high percentage of women experienced hot flashes at the end of treatment and at six-month follow-up. A significant association of hot flashes severity with spiritual practice, increased vitamin use, and reduced exercise emphasize the need for future studies to confirm the results. This can facilitate safe use of complementary and alternative medicine and favorable outcomes while managing cancer-related hot flashes.

show abstract

“…Such individuals, who are often overwhelmingly anxious about the implications of their diagnosis and preoccupied with treatment decisions, may be unwilling or unable to consider participation in a research project or even to provide informed consent at such a time of personal upheaval. In research that has been conducted to investigate the frequency of traumatic stress disorders in cancer patients, ASD was identified in approximately one quarter of patients with brain cancer, localized breast cancer, and first‐onset head and neck, or lung cancers . The adverse effects of full and threshold ASD and PTSD on health outcomes, quality of life, and survival in other populations highlight the clinical relevance of these findings.…”

Section: The Trauma Of Life‐threatening Disease Of Acute Onsetmentioning

confidence: 99%

From evidence to implementation: The global challenge for psychosocial oncology

Rodin

2018

Psycho-Oncology

View full text Add to dashboard Cite

The human dimensions of medical care were highlighted by such pioneering figures as Cicely Saunders, Elizabeth Kubler-Ross, and Jimmie Holland and their tireless advocacy helped to build an evidence base for psychosocial and palliative interventions. In that spirit, we studied physical and psychological distress in advanced cancer and modeled pathways to distress in this population. We considered acute stress disorder as the prototype for psychological disturbances following the acute onset of life-threatening disorders, showing that it occurred in one-third of patients after the diagnosis of acute leukemia. To treat and prevent these symptoms, we developed Emotion and Symptom-focused Engagement (EASE), an integrated psychotherapeutic and early palliative intervention. We showed that EASE reduced both traumatic stress and physical suffering in these patients and a large multi-center trial is now underway. We also identified symptoms of depression and hopelessness n one quarter of patients with metastatic and advanced cancer, with worsening toward the end of life. To alleviate this distress, we developed a brief supportive-expressive therapy, referred to as Managing Cancer and Living Meaningfully (CALM). We showed in a large RCT that CALM improves depression, distress related to dying and death, and preparation for the end of life. We have now launched a global initiative involving 20 sites to date across North and South America, Europe, Australia, and Asia to have CALM implemented routinely in cancer care. Such initiatives are needed to move psychosocial care in cancer from evidence to implementation and to fulfill the dream of Jimmie Holland that cancer care be as humanistic as it is effective.

show abstract

Acute stress in patients with brain cancer during primary care

Cited by 35 publications

References 46 publications

Suicidal ideation, depression, and health-related quality of life in patients with benign and malignant brain tumors: a prospective observational study in 83 patients

Suicidal ideation, depression, and health-related quality of life in patients with benign and malignant brain tumors: a prospective observational study in 83 patients

Hot flashes severity, complementary and alternative medicine use, and self-rated health in women with breast cancer

From evidence to implementation: The global challenge for psychosocial oncology

Contact Info

Product

Resources

About